Mucus has been shown to tame microbes in new study
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
List view / Grid view
Antibiotics are a type of antimicrobial drug used in the treatment and prevention of bacterial infections.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
A technique to 'trick' bacteria into revealing pores in their cell walls has been developed and targeting these could make antibiotics more effective.
New antibiotics could be designed by discovering the mechanism a weapon bacteria uses to vanquish their competitors.
Researchers have used a high-throughput screening method to test over 125,000 molecules and identify a new class of antibiotics.
It is predicted that there will be 70 new monoclonal antibody (mAb) biotherapeutics available by 2020.
A new study has demonstrated the possibility of treating antibiotic-resistant Pseudomonas aeruginosa which causes sepsis in burn patients.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
A molecular switch that impacts immune responses to viral infections has been identified which could lead to better strategies to develop vaccines.
Using a novel technique, researchers have created new molecules effective at killing bacteria, providing new antibiotic drug targets.
Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
All biological therapeutics have the potential to induce an immunemediated response ranging from benign to severe adverse effects.
The advent of immune checkpoint inhibitors is a major breakthrough in cancer immunotherapy...
Researchers have identified the mechanism by which highly toxic compounds communicate, and how they use vesicles to be transported...
The team used techniques used by physicists along with highly specialised equipment to investigate deep into the bacterial membrane...
Researchers have paved the path towards redesigning antibiotics through the alteration of the peptide assembly involved in the process...